Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 10, 2026

On Aug 10, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$76.76 for US$576K under a trading plan, leaving 377,820 shares. Filed Aug 10, 2026 (Form 4).

Sold
7,500 shares
Price
US$76.76
Value
US$576K
Holding after
377,820 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockOption exercise7,500US$10.60385,320Direct
Aug 10, 2026Common StockSale7,500US$76.76377,820Direct

Source

View original at SEC

Related